NMTC
Neuroone Medical Technologies Corp
NASDAQ: NMTC · HEALTHCARE · MEDICAL DEVICES
$4.70
+0.00% today
Updated 2026-04-30
Market cap
$38.95M
P/E ratio
—
P/S ratio
3.32x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$3 – $7
Volume
0.2M
Neuroone Medical Technologies Corp (NMTC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1167.00 | $5398.00 | $921.00 | $921.00 | $1249.00 | $773.00 | $742.00 | $0.00 | $0.00 | $0.00 | $1.93M | $178146.00 | $171169.00 | $1.95M | $3.45M | $12.10M |
| Revenue growth (YoY) | — | +362.6% | -82.9% | +0.0% | +35.6% | -38.1% | -4.0% | -100.0% | — | — | — | -90.8% | -3.9% | +1040.7% | +76.9% | +250.4% |
| Cost of revenue | — | $2138.00 | — | — | — | $0.00 | $0.00 | $7740.00 | $21667.00 | $27569.00 | $70552.00 | $275895.00 | $241963.00 | $1.50M | $2.37M | $3.96M |
| Gross profit | $1167.00 | $3260.00 | $921.00 | $921.00 | $1249.00 | $773.00 | $742.00 | $-7740.00 | $-21667.00 | $-27569.00 | $1.86M | $-97749.00 | $-70794.00 | $456517.00 | $1.08M | $8.14M |
| Gross margin | 100.0% | 60.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — | 96.3% | -54.9% | -41.4% | 23.4% | 31.3% | 67.3% |
| R&D | — | — | — | — | — | $2400.00 | $735333.00 | $735333.00 | $951064.00 | $1.53M | $2.08M | $3.93M | $4.93M | $6.94M | $5.07M | $4.98M |
| SG&A | $7211.00 | $30688.00 | $14654.00 | $14654.00 | $26342.00 | $36687.00 | $49587.00 | $32611.00 | $3.22M | $4.28M | $4.75M | $5.92M | $6.71M | $6.75M | $7.79M | $7.38M |
| Operating income | $-6044.00 | $-27428.00 | $-13733.00 | $-13733.00 | $-19632.00 | $-35914.00 | $-30915.00 | $-32611.00 | $-3.21M | $-5.81M | $-4.90M | $-10.22M | $-10.03M | $-11.96M | $-11.89M | $-4.23M |
| Operating margin | -517.9% | -508.1% | -1491.1% | -1491.1% | -1571.8% | -4646.1% | -4166.4% | — | — | — | -254.5% | -5735.9% | -5860.2% | -612.3% | -344.3% | -34.9% |
| EBITDA | $-6044.00 | $-27428.00 | — | $-13733.00 | $-19632.00 | $-35584.00 | $-30915.00 | $-14978.00 | $-4.15M | $-5.79M | $-4.85M | $-9.80M | $-9.91M | $-11.76M | $-11.84M | $-3.01M |
| EBITDA margin | -517.9% | -508.1% | 0.0% | -1491.1% | -1571.8% | -4603.4% | -4166.4% | — | — | — | -252.0% | -5500.0% | -5790.9% | -602.1% | -343.0% | -24.9% |
| EBIT | $-6044.00 | $-27428.00 | $-13733.00 | $-13733.00 | $-19632.00 | $-35914.00 | $-30915.00 | $-32611.00 | $-4.17M | $-5.81M | $-4.93M | $-9.95M | $-10.03M | $-11.96M | $-12.09M | $-3.27M |
| Interest expense | $0.00 | $176.00 | $0.00 | $227.00 | $5461.00 | $330.00 | $14018.00 | $0.00 | $1.40M | $284557.00 | $7.52M | $3053.00 | $31152.00 | $0.00 | $228988.00 | $334063.00 |
| Income tax | — | — | — | — | — | $0.00 | $31948.00 | $15164.00 | $3.00 | $284557.00 | $7.52M | $274175.00 | $-109865.00 | $31371.00 | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -103.3% | -46.5% | -0.0% | -4.4% | -123.0% | -2.8% | 1.1% | -0.3% | 0.0% | 0.0% |
| Net income | $-6044.00 | $-27604.00 | $-13960.00 | $-13960.00 | $-30554.00 | $-36244.00 | $-62863.00 | $-47775.00 | $-6.83M | $-6.78M | $-13.64M | $-9.95M | $-10.00M | $-11.86M | $-12.32M | $-3.61M |
| Net income growth (YoY) | — | -356.7% | +49.4% | +0.0% | -118.9% | -18.6% | -73.4% | +24.0% | -14189.4% | +0.7% | -101.1% | +27.1% | -0.5% | -18.6% | -3.9% | +70.7% |
| Profit margin | -517.9% | -511.4% | -1515.7% | -1515.7% | -2446.3% | -4688.7% | -8472.1% | — | — | — | -708.0% | -5584.3% | -5842.0% | -607.4% | -356.7% | -29.8% |